![Michael K. McGarrity](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael K. McGarrity
Algemeen Directeur bij MDXHEALTH SA
Vermogen: - $ op 30-06-2024
Actieve functies van Michael K. McGarrity
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MDXHEALTH SA | Directeur/Bestuurslid | 18-02-2019 | - |
Algemeen Directeur | 18-02-2019 | - | |
LeviSense Medical, Inc. | Voorzitter | - | - |
MDxHealth, Inc.
![]() MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - |
Loopbaan van Michael K. McGarrity
Eerdere bekende functies van Michael K. McGarrity
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sterilis Solutions, LLC
![]() Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Algemeen Directeur | 01-06-2017 | 01-01-2018 |
NANOSPHERE, INC. | Directeur/Bestuurslid | 19-02-2013 | 01-09-2016 |
Algemeen Directeur | 13-02-2013 | 01-09-2016 | |
President | 13-02-2013 | 01-09-2016 | |
Verkoop & Marketing | 01-09-2005 | 01-01-2013 | |
STRYKER CORPORATION | Verkoop & Marketing | 01-01-1993 | 01-01-2005 |
Opleiding van Michael K. McGarrity
University of Notre Dame | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
België | 2 |
Operationeel
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Sales & Marketing | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
MDXHEALTH SA | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Nanosphere, Inc.
![]() Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
Sterilis Solutions, LLC
![]() Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Health Technology |
LeviSense Medical, Inc. | |
MDxHealth, Inc.
![]() MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Health Technology |